Biotech Acquisition Company pirced its IPO of 20 million units at $10 per unit to raise $200 million.
The SPAC’s target sector is the healthcare industry, with a particular focus on life sciences/biotechnology, healthcare information technology, medical technology and technology-enabled healthcare service sectors.
The SPAC is led by Dr. Michael Shleifer, chairman and CEO. Shleifer spent four years at L’Oréal before co-founding SPRIM in 2001. SPRIM now employs over 500 people in 17 countries, providing consulting and CRO services and stewarding life science clients through the development and delivery of commercially successful health solutions.
Units begin trading today on the Nasdaq under BIOTU. Read more.
